Blog Archives
Influence of comorbidity of cerebrovascular disease and amyloid-β on Alzheimer’s disease
Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe CC, Villemagne VL, Salvado O, Desmond PM, Masters CL (2020).
Plasma Amyloid-beta Biomarker Associated with Cognitive Decline in Preclinical Alzheimer’s Disease
Lim YY, Maruff P, Kaneko N, Doecke J, Fowler C, Villemagne VL, Kato T, Rowe CC, Arahata Y, Iwamoto S, Ito K, Tanaka K, Yanagisawa K, Masters CL, Nakamura A (2020).
Association of deficits in short-term learning and Abeta and hippocampal volume in cognitively normal adults
Lim YY, Baker JE, Bruns L, Jr., Mills A, Fowler C, Fripp J, Rainey-Smith SR, Ames D, Masters CL, Maruff P (2020).
Comorbidity of Cerebrovascular and Alzheimer’s Disease in Aging
Xia Y, Yassi N, Raniga P, Bourgeat P, Desmond P, Doecke J, Ames D, Laws SM, Fowler C, Rainey-Smith SR, Martins R, Maruff P, Villemagne VL, Masters CL, Rowe CC, Fripp J, Salvado O, AIBL (2020).
Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer’s disease
Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V, Fripp J, Ames D, Masters CL, Rowe CC, Connelly A, Villemagne VL, Salvado O, AIBL (2020).
Total Aβ(42)/Aβ(40) ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
Doecke JD, Pérez-Grijalba V, Fandos N, Fowler C, Villemagne VL, Masters CL, Pesini P, Sarasa M (2020).
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
Burnham SC, Fandos N, Fowler C, Pérez-Grijalba V, Dore V, Doecke JD, Shishegar R, Cox T, Fripp J, Rowe C, Sarasa M, Masters CL, Pesini P, Villemagne VL (2020).
Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer’s Disease
Lim WLF, Huynh K, Chatterjee P, Martins I, Jayawardana KS, Giles C, Mellett NA, Laws SM, Bush AI, Rowe CC, Villemagne VL, Ames D, Drew BG, Masters CL, Meikle PJ, Martins RN (2020).
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer’s disease
Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, Bourgeat P, Li QX, Collins S, Bush AI, Rowe CC, Masters CL, Ames D, Hone E, Blennow K, Zetterberg H, Martins RN (2020).
Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
Zhang Q, Sidorenko J, Couvy-Duchesne B, Marioni RE, Wright MJ, Goate AM, Marcora E, Huang KL, Porter T, Laws SM, AIBL, Sachdev PS, Mather KA, Armstrong NJ, Thalamuthu A, Brodaty H, Yengo L, Yang J, Wray NR, McRae AF, Visscher PM (2020).